Nakagawa, Natsuki
Hashii, Yoshiko http://orcid.org/0000-0003-1668-274X
Kayama, Hisako
Okumura, Ryu
Nakajima, Hiroko
Minagawa, Hikaru
Morimoto, Soyoko
Fujiki, Fumihiro
Nakata, Jun
Shirakawa, Toshiro
Katayama, Takane
Takeda, Kiyoshi
Tsuboi, Akihiro
Ozono, Keiichi
Funding for this research was provided by:
Japan Society for the Promotion of Science Grants in Aid for Scientific Research (17K16258, 17K10109)
Translational Research Program, Strategic Promotion for Practical Application of Innovative Medical Technology (TR-SPRINT) from the Japan Agency for Medical Research and Development (17lm0203036h0001)
Translational Research Program, Strategic Promotion for Practical Application of Innovative Medical Technology (TR-SPRINT) from the Japan Agency for Medical Research and Development (19lm0203091s0101)
Article History
Received: 15 June 2021
Accepted: 25 April 2022
First Online: 14 June 2022
Declarations
:
: TS, TK, and YH are the co-inventors on related vaccine patents. All authors have nothing to declare about this study.
: Our study was approved by Osaka University Animal Experiment Committee. Osaka University’s Safety Management Regulations on Recombinant DNA Experiment.